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Rezumat
Medicația asociată și impactul ei asupra sănătății locui-
torilor județelor Galați și Brăila
Autorii studiului au urmărit scopul ca, prin anchetarea unor 
grupe de locuitori din județele Galați și Brăila, să deter-
mine dacă aceștia au cunoștințe despre medicația asociată, 
de exemplu, despre probiotice și hepatoprotectoare. De 
asemenea, s-a încercat de a clarifi ca dacă asemenea pre-
parate au fost recomandate de medic sau farmacist, ori țin 
de autolecuire.
Cuvinte-cheie: probiotice, hepatoprotectoare, comuni-
care
Резюме
Ассоциированная медикация и её влияние на здоровье 
населения округов Галаць и Брэила
В  данной  статье  авторы  поставили  перед 
собой цель, чтобы при использовании метода 
анкетирования некоторых групп населения округов 
Галаць и Брэила выявить, если им известно об 
ассоциированной медикации, например, о пробиотиках 
и хепатопротекторах, а также выяснить, если 
эта медикация была рекомендована врачом или 
фармацевтом или она из категории самолечения. 
Ключевые слова: пробиотики, хепатопротекторы, 
коммуникация
Introduction
Communication for health purposes or promo-
ting health through communication is one of the 
instruments for improving health. When one speaks 
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about health, one actually understands healthcare, 
and pharmaceutical services, respectively.
Education for health purposes and promoting 
health in Romania in agreement with the interna-
tional standards, and especially with the European 
Union standards [1] is required. The legal framework 
for public healthcare and the national public health-
care programmes are established and funded by 
Ministry of Public Health, as provided by Law 95/ 
2005 of the healthcare reform.
In dealing with this matter, Romania observes 
the EU legislation, which stipulates that “the aim of 
protecting health is that of improving the general 
standards of health in the community by improving 
knowledge of the risk factors and encouraging the 
population to embrace healthy behaviours and 
lifestyles”.
Words or silence, a smile or a handshake, a 
warm or a chilling look – whether we want it or 
not – everything signifies and communicates. We 
communicate to transfer ideas, sentiments, emoti-
ons, opinions, to influence, to relate to each other, 
to work, or to socialise. Sartre said: “the other looks 
at me and as such he knows what I am”.
It has been demonstrated that the human 
being expresses 7% through language, 38% through 
paraverbal language and 55% through non-verbal 
language. Another essential component of com-
munication is listening. Goethe said: “Speaking is a 
necessity. Listening is an art.” Listening is a sine qua 
non requisition of effective communication. 
Materials and methods
This study employs the questionnaire method 
to assess, on the one hand, the extent to which phar-
macists and physicians get involved in recommen-
ding associated medication, and on the other hand, 
to evaluate patients with regard to their knowledge 
of associated medication, probiotics and hepatopro-
tectors, respectively.
According to the definition of World Health 
Organisation, “probiotics are live micro-organisms 
which, when administered in adequate amounts, 
confer a health benefit on the host”. Probiotics are 
live micro-organisms physiologically present in the 
gastro-intestinal tract and they have a significant role 
in digestion and immunity. It is equally interesting to 
know that the total amount of live micro-organisms 
in the gastro-intestinal tract is about one hundred 
billions, which is ten times more than the totality of 
cells in the human body [2].
Probiotic bacteria have many functions in or-
ganism: they act as a barrier and for the inactivation 
of pathogen germs; metabolic function owed to the 
enzyme production and fermentation of indigesti-
ble carbohydrates in view of reducing cholesterol 
or easing the production of energy; nutritional and 
immunising functions [1].
An analysis conducted in 2004 [3] on the studies 
on probiotics pursued until that year reached the 
conclusion that multiple probiotic strains are more 
effective than mono-strain probiotics, which is due 
the fact that a number of favourable characteristics 
of individual strains may be combined in a single 
probiotic. Clinical studies [4] have proved the syner-
getic effects of strains combinations. For example, 
the binding of Bifidobacteriumlactis to intestinal cells 
doubles in the presence of Lactobacillus Rhamnosus 
or Lactobacillus bulgaricusstrains.
Other clinical studies [5] have demonstrated 
that the adherence of these beneficial probiotics 
to the intestinal wall mucus increases when more 
strains are present in the combinations administe-
red. 
It is required that the probiotics be kept away 
from humidity and protected by cryoprotection 
technologies of acid-lactic bacteria, be in amounts 
of billions to give the chance to many to reach the 
intestine, contain combinations of live bacteria and 
thermally-inactive bacteria in order to have fast 
effects and increase their specific effects, based on 
administering indication.
Starting from the premise of a good commu-
nication between pharmacist and patient, in the 
context of communication for health purposes as an 
essential factor of promoting health in the communi-
ty, our study has focused on a sample made up of 304 
persons domiciled both in the urban environment 
(Galati, Braila), and in the rural environment (Liesti 
village, Galati County). 61.5% of the subjects were 
female, and 38.5% male, aged between 17 and 82 
years.
The general objective of the study was to 
determine the patients’ level of awareness in what 
associated medication is concerned, respectively 
probiotics and hepatoprotectors, as well as the 
pharmacists’ skills in counselling the patients with 
regard to associated medication. The specific ob-
jectives have been:
• To assess the extent to which patients know 
what associated medication means;
• To assess the extent to which patients use 
associated medication and to find out who 
recommended it to them;
• To evaluate the pharmacists’ communication 
skills in the relationship with their patients.
We have applied a 13-question questionnaire, 
presented electronically, online, to respondents, with 
the help of social networking sites, and also directly, 
handed personally to the respondents.
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Results and discussions
The first question was related to the pharmacist’s 
professionalism, i.e., whether before making a recom-
mendation, the pharmacist makes a brief anamnesis 
with the patient. 53% of the respondents answered 
affirmatively; 35.9% – rarely; 11.2% – never.
The next question interrogated the patient, i.e., 
their knowledge related to associated medication. 
77% of the respondents know the term “associated 
medication”; 41.8% responded “yes”; 45.8% of the 
interviewees use associated medication. It results 
that patients know and use associated medication.
The question as to whether medication was 
recommended by the pharmacist, physician, other 
people or the mass-media indicates that most peo-
ple have been given recommendation in this respect 
at the pharmacy.
Associated medication was recommended to 
you by:
• Physician – 31.5%;
• Pharmacist – 39.3%;
• Family, friends, acquaintances – 13.7%;
• Media (internet, magazines, news, TV or radio 
advertisements, etc.) – 15.5%.
The following answers have been recorded to 
the question “When do you think that associated 
medication is required?”:
• Stomach diseases – 28.5%;
• Liver diseases – 28.2%;
• Child medication – 17.2%;
• Antibiotics treatment – 23.2%;
• I don’t know, I have never been informed regar-
ding this matter – 3.4%.
In the case of antibiotic treatment, has the 
pharmacist recommended you any medicine for 
protection of intestinal flora?
• Always – 16.8%;
• Yes, in most cases – 46.1%;
• Sometimes – 26.6%;
• Never – 10.5%.
Do you use gastric protection in treatments 
which affect gastric mucosa?
• Yes, at the pharmacist’s recommendation – 
59.6%;
• I don’t know, I have never been informed about 
this matter – 8.2%;
• No, because I don’t have any problems – 
32.2%.
We note once again the good communication 
of the patients with the pharmacist, as well as the 
pharmacists’ professionalism in getting themselves 
involved in recommending associated medication.
We were also interested in determining whether 
the pharmacist also makes further recommendations 
associated with the diagnosis.
Does the pharmacist inform you that your lifes-
tyle and dietary habits can affect your medication?
• Always – 33%;
• Rarely – 52.4%;
• Never – 14.9%.
In the end, we wanted to find out the patients’ 
opinion with regard to associated medication and 
the impact it has on them.
What is your opinion about associated medi-
cation?
• You approve of it and consider it useful – 
58.9%;
• You consider it useful only in case of serious 
diseases – 28.6%;
• You do not approve of it and consider that it 
is recommended to you only to sell certain 
medical products – 12.5%.
The high percentage (58.9%) of respondents 
who consider associated medication useful lead us 
to the conclusion that our patients are well informed 
and that they have a good communication with the 
pharmacists.
Conclusions
Patients know what associated medication is, 
respectively probiotics and hepatoprotectors, and 
women are more receptive to it than men. Associated 
medication is recommended by both physicians and 
pharmacists.
Pharmacists inform their patients with regard to 
associated medication in most cases, and the latter 
are open to suggestions.
The results indicate that most pharmacists pur-
sue their professional duties in accordance with the 
procedures provided by the rules of good practice 
in their field. 
Promoting health through communication is 
“the place where good practices of promoting health 
meet good communication practices” [6]. 
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